Related Experiment Video
Updated: Jun 26, 2025

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative
Farah Ramadan1,2,3,4, Raya Saab5,6,7, Farah Ghamloush5
1Université Lyon 1, Lyon, France.
Abstract:
Rhabdomyosarcoma is a pediatric cancer associated with aggressiveness and a tendency to develop metastases. Fusion-negative rhabdomyosarcoma (FN-RMS) is the most commonly occurring subtype of RMS, where metastatic disease can hinder treatment success and decrease survival rates. RMS-derived exosomes were previously demonstrated to be enriched with miRNAs, including miR-1246, possibly contributing to disease aggressiveness. We aimed to decipher the functional impact of exosomal miR-1246 on recipient cells and its role in promoting aggressiveness. Treatment of normal fibroblasts with FN-RMS-derived exosomes resulted in a significant uptake of miR-1246 paired with an increase in cell proliferation, migration, and invasion. In turn, delivery of miR-1246-mimic lipoplexes promoted fibroblast proliferation, migration, and invasion in a similar manner. Conversely, when silencing miR-1246 in FN-RMS cells, the resulting derived exosomes demonstrated reversed effects on recipient cells' phenotype. Delivery of exosomal miR-1246 targets GSK3β and promotes β-catenin nuclear accumulation, suggesting a deregulation of the Wnt pathway, known to be important in tumor progression. Finally, a pilot clinical study highlighted, for the first time, the presence of high exosomal miR-1246 levels in RMS patients' sera. Altogether, our results demonstrate that exosomal miR-1246 has the potential to alter the tumor microenvironment of FN-RMS cells, suggesting its potential role in promoting oncogenesis.
Insights
Exosomal miR-1246 from fusion-negative rhabdomyosarcoma (FN-RMS) promotes cancer cell aggressiveness. Targeting this microRNA may offer new therapeutic strategies for pediatric rhabdomyosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Rhabdomyosarcoma (RMS) is a pediatric cancer characterized by aggressiveness and metastasis.
- Fusion-negative RMS (FN-RMS) is the most common subtype, with metastasis significantly impacting survival.
- Exosomes from RMS cells contain microRNAs (miRNAs), including miR-1246, potentially driving disease aggressiveness.
Purpose of the Study:
- To investigate the functional role of exosomal miR-1246 in promoting FN-RMS aggressiveness.
- To determine the impact of exosomal miR-1246 on recipient cell behavior and underlying molecular mechanisms.
- To assess the clinical relevance of exosomal miR-1246 levels in rhabdomyosarcoma patients.
Main Methods:
- Treatment of normal fibroblasts with FN-RMS-derived exosomes and miR-1246 mimics.
- Silencing miR-1246 in FN-RMS cells and analyzing the effects of derived exosomes.
- Investigating the molecular targets of exosomal miR-1246, including GSK3β and the Wnt pathway.
- Analyzing serum samples from RMS patients for exosomal miR-1246 levels.
Main Results:
- FN-RMS exosomes carrying miR-1246 significantly increased fibroblast proliferation, migration, and invasion.
- Delivery of miR-1246 mimics replicated these pro-aggressive effects.
- Silencing miR-1246 in FN-RMS cells reversed the pro-metastatic effects of their exosomes.
- Exosomal miR-1246 was found to target GSK3β, promoting Wnt pathway activation.
- Elevated exosomal miR-1246 levels were detected in RMS patients' sera.
Conclusions:
- Exosomal miR-1246 actively promotes FN-RMS aggressiveness by altering the tumor microenvironment.
- miR-1246 influences recipient cell behavior through GSK3β targeting and Wnt pathway deregulation.
- Exosomal miR-1246 represents a potential biomarker and therapeutic target for rhabdomyosarcoma.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...

